2001
DOI: 10.1053/jhin.2001.0938
|View full text |Cite
|
Sign up to set email alerts
|

An economic model to assess the cost and benefits of the routine use of silver alloycoated urinary catheters to reduce the risk of urinary tract infections in catheterized patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
35
0
1

Year Published

2003
2003
2017
2017

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 68 publications
(36 citation statements)
references
References 27 publications
0
35
0
1
Order By: Relevance
“…Several studies of the effect of incorporating antibiotics such as rifampicin and minocycline (Darouchie et al, 1999) or silver based alloys (Newton et al, 2002) into the catheter have shown benefit. Although clearly more costly than standard catheters, economic evaluation shows silver alloy catheters to be cost effective when used in patients needing catheterization for several days (Plowman et al, 2001). The prevalence of asymptomatic bacteriuria of pregnancy is approximately 5%, about a third of these women proceed to develop acute pyelonephritis, with its attendant consequences for the health of both mother and pregnancy.…”
Section: Introductionmentioning
confidence: 99%
“…Several studies of the effect of incorporating antibiotics such as rifampicin and minocycline (Darouchie et al, 1999) or silver based alloys (Newton et al, 2002) into the catheter have shown benefit. Although clearly more costly than standard catheters, economic evaluation shows silver alloy catheters to be cost effective when used in patients needing catheterization for several days (Plowman et al, 2001). The prevalence of asymptomatic bacteriuria of pregnancy is approximately 5%, about a third of these women proceed to develop acute pyelonephritis, with its attendant consequences for the health of both mother and pregnancy.…”
Section: Introductionmentioning
confidence: 99%
“…2 It has been argued that the economic benefits of prevention are likely to exceed the costs. 3 " 5 Data on the costs of hospital-acquired infection and the cost-effectiveness of prevention programs should be made available to policymakers. However, before these data can be procured, it is necessary to understand the size and the extent of the problem.…”
mentioning
confidence: 99%
“…For the background to our planned economic evaluation we performed a systematic literature search that identified 400 economic studies, of which six reports 5,[60][61][62][63][64] and two systematic reviews 65,66 were deemed relevant, although only one was from the perspective of the UK NHS.…”
Section: Cost-effectivenessmentioning
confidence: 99%
“…A UK NHS-based study 61 reported that if routine use of silver alloy-coated catheters was adopted, and assuming an additional cost of £9 per catheter, lower costs of extra hospital stay in medical patients, and a baseline risk for CAUTI of 7.3%, relative risk reductions in CAUTI of 14.6% in catheterised medical patients, and of 11.4% in catheterised surgical patients were required before cost savings could be made.…”
mentioning
confidence: 99%